Correlation of Diffusion Tensor and Dynamic Perfusion MR Imaging Metrics in Normal-Appearing Corpus Callosum: Support for Primary Hypoperfusion in Multiple Sclerosis

References

1. ↵
   Trotter JL, Wegescheide CL, Garvey WF, et al. Studies of myelin proteins in multiple sclerosis brain tissue. Neurochem Res 1984;9:147–52

   CrossRefPubMed
2. ↵
   Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–85

   CrossRefPubMedWeb of Science
3. ↵
   Traugott U, Reinherz EL, Raine CS. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983;4:201–21

   CrossRefPubMedWeb of Science
4. ↵
   Adams CW. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull 1977;33:15–20

   FREE Full Text
5. ↵
   Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385–91

   CrossRefPubMedWeb of Science
6. Husted CA, Goodin DS, Hugg JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 1994;36:157–65

   CrossRefPubMedWeb of Science
7. ↵
   Davie CA, Barker GJ, Thompson AJ, et al. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:736–42

   Abstract/FREE Full Text
8. ↵
   Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478–82

   Abstract/FREE Full Text
9. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–15

   CrossRefPubMedWeb of Science
10. ↵
    Ge Y, Grossman RI, Udupa JK, et al. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 2002;26:62–68

    CrossRefPubMedWeb of Science
11. ↵
    Law M, Saindane AM, Ge Y, et al. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 2004;231:645–52

    CrossRefPubMedWeb of Science
12. ↵
    Thomalla G, Glauche V, Weiller C, et al. Time course of wallerian degeneration after ischaemic stroke revealed by diffusion tensor imaging. J Neurol Neurosurg Psychiatry 2005;76:266–68

    Abstract/FREE Full Text
13. ↵
    Khong PL, Zhou LJ, Ooi GC, et al. The evaluation of Wallerian degeneration in chronic paediatric middle cerebral artery infarction using diffusion tensor MR imaging. Cerebrovasc Dis 2004;18:240–47

    CrossRefPubMedWeb of Science
14. ↵
    Thomalla G, Glauche V, Koch MA, et al. Diffusion tensor imaging detects early wallerian degeneration of the pyramidal tract after ischemic stroke. NeuroImage 2004;22:1767–74

    CrossRefPubMedWeb of Science
15. ↵
    Werring DJ, Toosy AT, Clark CA, et al. Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry 2000;69:269–72

    Abstract/FREE Full Text
16. ↵
    Pierpaoli C, Barnett A, Pajevic S, et al. Water diffusion changes in wallerian degeneration and their dependence on white matter architecture. Neuroimage 2001;13:1174–85

    PubMedWeb of Science
17. ↵
    Werring DJ, Clark CA, Barker GJ, et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–32

    Abstract/FREE Full Text
18. Filippi M. Linking structural, metabolic and functional changes in multiple sclerosis. Eur J Neurol 2001;8:291–97

    CrossRefPubMedWeb of Science
19. Bammer R, Keeling SL, Augustin M, et al. Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001;46:548–54

    CrossRefPubMedWeb of Science
20. ↵
    Guo AC, MacFall JR, Provenzale JM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002;222:729–36

    CrossRefPubMedWeb of Science
21. ↵
    Werring DJ, Clark CA, Droogan AG, et al. Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions. Mult Scler 2001;7:83–89

    Abstract/FREE Full Text
22. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–31

    CrossRefPubMedWeb of Science
23. ↵
    Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11

    Abstract/FREE Full Text
24. ↵
    Reese TG, Heid O, Weisskoff RM, et al. Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo. Magn Reson Med 2003;49:177–82

    CrossRefPubMedWeb of Science
25. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

    CrossRefPubMedWeb of Science
26. ↵
    Rempp KA, Brix G, Wenz F, et al. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994;193:637–41

    CrossRefPubMedWeb of Science
27. ↵
    Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25

    CrossRefPubMedWeb of Science
28. ↵
    Ostergaard L, Sorensen AG, Kwong KK, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn Reson Med 1996;36:726–36

    CrossRefPubMedWeb of Science
29. ↵
    Basser PJ. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed 1995;8:333–44

    CrossRefPubMedWeb of Science
30. ↵
    Carroll TJ, Rowley HA, Haughton VM. Automatic calculation of the arterial input function for cerebral perfusion imaging with MR imaging. Radiology 2003;227:593–600

    CrossRefPubMedWeb of Science
31. ↵
    Allen IV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81–91

    CrossRefPubMedWeb of Science
32. ↵
    Evangelou N, Esiri MM, Smith S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391–95

    CrossRefPubMedWeb of Science
33. ↵
    Munoz Maniega SM, Bastin ME, Armitage PA, et al. Temporal evolution of water diffusion parameters is different in grey and white matter in human ischaemic stroke. J Neurol Neurosurg Psychiatry 2004;75:1714–18

    Abstract/FREE Full Text
34. ↵
    Buffon F, Molko N, Herve D, et al. Longitudinal diffusion changes in cerebral hemispheres after MCA infarcts. J Cereb Blood Flow Metab 2005;25:641–50

    CrossRefPubMed
35. ↵
    Pierpaoli C, Righini A, Linfante I, et al. Histopathologic correlates of abnormal water diffusion in cerebral ischemia: diffusion-weighted MR imaging and light and electron microscopic study. Radiology 1993;189:439–48

    CrossRefPubMedWeb of Science
36. ↵
    Sorensen AG, Wu O, Copen WA, et al. Human acute cerebral ischemia: detection of changes in water diffusion anisotropy by using MR imaging. Radiology 1999;212:785–92

    CrossRefPubMedWeb of Science
37. ↵
    Johnson AC, McNabb, Rossiter RJ. Chemistry of wallerian degeneration; a review of recent studies. Arch Neurol Psychiatry 1950;64:105–21

    CrossRefPubMed
38. ↵
    Tomasch J. Size, distribution, and number of fibres in the human corpus callosum. Anat Rec 1954;119:119–35

    CrossRefPubMedWeb of Science
39. ↵
    Ciccarelli O, Werring DJ, Barker GJ, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging–evidence of Wallerian degeneration. J Neurol 2003;250:287–92

    CrossRefPubMedWeb of Science
40. ↵
    De Stefano N, Narayanan S, Francis SJ, et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 2002;59:1565–71

    CrossRefPubMedWeb of Science
41. ↵
    Ranjeva JP, Pelletier J, Confort-Gouny S, et al. MRI/MRS of corpus callosum in patients with clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2003;9:554–65

    Abstract/FREE Full Text
42. ↵
    Adams CW, Poston RN, Buk SJ, et al. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci 1985;69:269–83

    CrossRefPubMedWeb of Science
43. ↵
    Putnam TJ. Evidences of vascular occlusion in multiple sclerosis and encephalomyelitis. Arch Neurol Neuropsychol 1935;32:1298–321
44. ↵
    Putnam TJ. The pathogenesis of multiple sclerosis: a possible vascular factor. N Engl J Med 1933;209:786–90

    CrossRefWeb of Science
45. ↵
    Wakefield AJ, More LJ, Difford J, et al. Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 1994;47:129–33

    Abstract/FREE Full Text
46. ↵
    Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458–68

    CrossRefPubMedWeb of Science
47. ↵
    Aboul-Enein F, Rauschka H, Kornek B, et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003;62:25–33

    PubMedWeb of Science
48. ↵
    Evangelou N, Konz D, Esiri MM, et al. Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain 2001;124:1813–20

    Abstract/FREE Full Text
49. ↵
    Aboitiz F, Scheibel AB, Fisher RS, et al. Fiber composition of the human corpus callosum. Brain Res 1992;598:143–53

    CrossRefPubMedWeb of Science
50. ↵
    Calamante F, Gadian DG, Connelly A. Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 2000;44:466–73

    CrossRefPubMed
51. ↵
    Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002;33:1146–51

    Abstract/FREE Full Text